Motor neuron disease: current management and future prospects
- 1 October 2015
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 45 (10) , 1005-1013
Abstract
Motor neuron disease (MND) is characterised by progressive neurological deterioration and coexistence of upper and lower motor neuron signs. Over the past decade, evidence has emerged of unique pathophysiological processes, including glutamate‐mediated excitotoxicity, which has resulted in the development of novel diagnostic investigations and uncovered potential therapeutic targets. Advances in genetics, including the recently discovered C9orf72 gene, have radically changed the pathological mindset, from MND being classified as a neuromuscular disease to one that MND forms a continuum with other primary neurodegenerative disorders, including frontotemporal dementia. The present review will highlight the improvements that have occurred in clinical care, in conjunction with recent scientific developments.Keywords
This publication has 61 references indexed in Scilit:
- Non-invasive ventilation in amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013
- The Puzzling Case of Hyperexcitability in Amyotrophic Lateral SclerosisJournal of Clinical Neurology, 2013
- Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insightsJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyThe Lancet Neurology, 2012
- Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: Effect on survivalJournal of the Neurological Sciences, 2011
- Amyotrophic lateral sclerosisThe Lancet, 2011
- Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)Neurology, 2009
- Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review)Neurology, 2009
- Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing GroupsPLOS ONE, 2009
- ALS motor phenotype heterogeneity, focality, and spreadNeurology, 2009